Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Jacoby, MD, PhD
Repligen Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Stanford, California, United States
- Carman Research
Smyrna, Georgia, United States
- Indiana University-Purdue University Indianapolis
Indianapolis, Indiana, United States
- Marc Hertzman, Md, Pc
Rockville, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Medical & Behavioral Health Research, Pc
New York, New York, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Future Search Trials of Austin
Austin, Texas, United States
- Future Search Trials of Dallas
Dallas, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- —
- Completion
- —
- Last update posted
- 9 Nov 2007
- Registered enrollment
- 80
- Registry id
- NCT00322764
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.